Improved outcomes in allogeneic hematopoietic cell transplant (allo HCT) patients treated with brincidofovir (CMX001, BCV) for disseminated adenovirus (AdV) disease compared to literature: Updated preliminary results from the AdVise (CMX001-304) study
Published in 2015 by
M. Grimley,
G. Papanicolaou 
,
G. Maron,
G. Chittick,
T. Brundage,
A. Bae,
H. Mommeja-Marin,
W. G. Nichols,
V. K. Prasad
,
G. Maron,
G. Chittick,
T. Brundage,
A. Bae,
H. Mommeja-Marin,
W. G. Nichols,
V. K. Prasad
